CQ

Christophe Queva

ML Medimmune Limited: 4 patents #167 of 738Top 25%
IS Iteos Therapeutics Sa: 1 patents #11 of 19Top 60%
ON Oncorus: 1 patents #4 of 6Top 70%
VC Virogin Biotech Canada: 1 patents #5 of 12Top 45%
📍 Cambridge, MA: #1,388 of 8,183 inventorsTop 20%
🗺 Massachusetts: #15,851 of 88,656 inventorsTop 20%
Overall (All Time): #595,418 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12208126 Oncolytic viral vectors and uses thereof Mitchell H. Finer, Lorena Lerner, Edward M. KENNEDY 2025-01-28
11612625 Oncolytic viral vectors and uses thereof Mitchell H. Finer, Lorena Lerner, Edward M. KENNEDY 2023-03-28
11518809 Targeted binding agents against B7-H1 Michelle Morrow, Scott Hammond, Marat Alimzhanov, John C. Babcock, Ian Foltz +6 more 2022-12-06
11439705 Anti-TIGIT antibodies Anthony B. Cooper, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens +1 more 2022-09-13
10400039 Targeted binding agents against B7-H1 Michelle Morrow, Scott Hammond, Marat Alimzhanov, John C. Babcock, Ian Foltz +6 more 2019-09-03
10329349 Anti-TIGIT antibodies Anthony B. Cooper, Sofie Denies, Catherine Hoofd, Julia Cuende, Gregory Driessens +1 more 2019-06-25
9493565 Targeted binding agents against B7-H1 Michelle Morrow, Scott Hammond, Marat Alimzhanov, John C. Babcock, Ian Foltz +6 more 2016-11-15
8779108 Targeted binding agents against B7-H1 Michelle Morrow, Scott Hammond, Marat Alimzhanov, John Babcook, Ian Foltz +6 more 2014-07-15